Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?

doi:10.4251/wjgo.v9.i3.98

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10009)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

560

WORD

332

HTML

4072

Figures (1-2)

415

Tables (1-1)

219

Sum=5598

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

725

Download

991

Sum=1716

Publishing Process of This Article

Item

Count

Browse

1120

Download

1575

Sum=2695

Mar 15, 2017 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Mar 15, 2017; 9(3): 98-104
Published online Mar 15, 2017. doi: 10.4251/wjgo.v9.i3.98

Full Size Figure Download Figure

Figure 2 Translational cancer research design for investigation of cancer biology. The illustration is based on the ACROBATICC (Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer) project flow, see main article for details. Reproduced with permission from Søreide et al[39]. J Transl Med 2016; 14 (1): 192. © 2016 Søreide et al. CEA: Carcino-embryonic antigen; CT: Computed tomography; MR: Magnetic resonance.

Citation: Veen T, Søreide K. Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis? World J Gastrointest Oncol 2017; 9(3): 98-104
URL: https://www.wjgnet.com/1948-5204/full/v9/i3/98.htm
DOI: https://dx.doi.org/10.4251/wjgo.v9.i3.98